Mentholum 1 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02234608) held by Dolisos Canada Inc., containing Menthol. Health Canada lists its status as Cancelled Post Market (status date 20 Apr 2006). Nexara Health has matched 1087 registrations of Menthol across 9 other regulated markets, 9 of them in the same strength and dosage form.

Health Canada registration

Menthol registered in other markets

1087 registrations of the same molecule in 9 national registries outside Canada (first 48 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Menthol worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Mentholum (DIN 02234608) marketed in Canada?

No. Health Canada lists DIN 02234608 as Cancelled Post Market as of 20 Apr 2006.

Who holds the Canadian licence for this product?

Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.

Is Menthol registered outside Canada?

Yes — Nexara Health has matched 1087 registrations in 9 other markets, including 9 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02234608, status date 2006-04-20; national medicine registries: BDA, DH Drug Office, EDE, FDA NDC, Medicines Authority, NHS dm+d VMP, NPRA, PBS, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02234608, status date 2006-04-20; national medicine registries: BDA, DH Drug Office, EDE, FDA NDC, Medicines Authority, NHS dm+d VMP, NPRA, PBS, TFDA.

Health Canada Drug Product Database (DPD), DIN 02234608, status date 2006-04-20; national medicine registries: BDA, DH Drug Office, EDE, FDA NDC, Medicines Authority, NHS dm+d VMP, NPRA, PBS, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.